X-153869924-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001278116.2(L1CAM):c.1002C>T(p.Tyr334Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000777 in 1,208,329 control chromosomes in the GnomAD database, including 7 homozygotes. There are 267 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0041 ( 2 hom., 137 hem., cov: 24)
Exomes 𝑓: 0.00043 ( 5 hom. 130 hem. )
Consequence
L1CAM
NM_001278116.2 synonymous
NM_001278116.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.00
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant X-153869924-G-A is Benign according to our data. Variant chrX-153869924-G-A is described in ClinVar as [Benign]. Clinvar id is 199019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00412 (463/112355) while in subpopulation AFR AF= 0.0145 (449/30978). AF 95% confidence interval is 0.0134. There are 2 homozygotes in gnomad4. There are 137 alleles in male gnomad4 subpopulation. Median coverage is 24. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L1CAM | NM_001278116.2 | c.1002C>T | p.Tyr334Tyr | synonymous_variant | 10/29 | ENST00000370060.7 | NP_001265045.1 | |
L1CAM | NM_000425.5 | c.1002C>T | p.Tyr334Tyr | synonymous_variant | 9/28 | NP_000416.1 | ||
L1CAM | NM_024003.3 | c.1002C>T | p.Tyr334Tyr | synonymous_variant | 9/27 | NP_076493.1 | ||
L1CAM | NM_001143963.2 | c.987C>T | p.Tyr329Tyr | synonymous_variant | 8/26 | NP_001137435.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L1CAM | ENST00000370060.7 | c.1002C>T | p.Tyr334Tyr | synonymous_variant | 10/29 | 5 | NM_001278116.2 | ENSP00000359077.1 | ||
L1CAM | ENST00000361699.8 | c.1002C>T | p.Tyr334Tyr | synonymous_variant | 9/27 | 1 | ENSP00000355380.4 | |||
L1CAM | ENST00000361981.7 | c.987C>T | p.Tyr329Tyr | synonymous_variant | 8/26 | 1 | ENSP00000354712.3 | |||
L1CAM | ENST00000370055.5 | c.987C>T | p.Tyr329Tyr | synonymous_variant | 9/27 | 5 | ENSP00000359072.1 |
Frequencies
GnomAD3 genomes AF: 0.00413 AC: 464AN: 112301Hom.: 2 Cov.: 24 AF XY: 0.00398 AC XY: 137AN XY: 34457
GnomAD3 genomes
AF:
AC:
464
AN:
112301
Hom.:
Cov.:
24
AF XY:
AC XY:
137
AN XY:
34457
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00113 AC: 198AN: 174874Hom.: 0 AF XY: 0.00101 AC XY: 63AN XY: 62596
GnomAD3 exomes
AF:
AC:
198
AN:
174874
Hom.:
AF XY:
AC XY:
63
AN XY:
62596
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000434 AC: 476AN: 1095974Hom.: 5 Cov.: 34 AF XY: 0.000359 AC XY: 130AN XY: 361830
GnomAD4 exome
AF:
AC:
476
AN:
1095974
Hom.:
Cov.:
34
AF XY:
AC XY:
130
AN XY:
361830
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00412 AC: 463AN: 112355Hom.: 2 Cov.: 24 AF XY: 0.00397 AC XY: 137AN XY: 34521
GnomAD4 genome
AF:
AC:
463
AN:
112355
Hom.:
Cov.:
24
AF XY:
AC XY:
137
AN XY:
34521
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 07, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 12, 2014 | - - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2025 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 05, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at